Brazil’s Hypermarcas Plans to Buy Back $300 Million of 2021 Bonds

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hypermarcas SA, the largest Brazilian producer of generic drugs and beauty care products, plans to repurchase 40 percent, or $300 million, of the $750 million in outstanding global bonds due in 2021, in a bid to reduce debt. The São Paulo-based company will offer a $67.50 premium and a $30 early participation fee to investors per every $1,000 worth of the notes tendered, according to a statement. Holders of the notes who tender the 6.5 percent bond after the early tender period expires at 5 p.m. New York time on Nov. 8 but before the expiration date will not be entitled to receive the fee, the statement added.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC